Sanofi-Aventis to buy Brazilian generics giant
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis is to acquire the Brazilian generics firm Medley in a move that will make it Latin America's biggest generic medicines company. This comes after Sanofi-Aventis's acquisition of the Mexican generics company Kendrick last week (scripnews.com, April 8th, 2009).